DSpace Fukushima Medical University

福島県立医科大学学術成果リポジトリ = Fukushima Medical University Repository >
福島医学会 = The Fukushima Society of Medical Science >
Fukushima Journal of Medical Science >
Vol.51 (2005) >

Please use this identifier to cite or link to this item: http://ir.fmu.ac.jp/dspace/handle/123456789/171

Files in This Item:

File Description SizeFormat
FksmJMedSci_51_p51.pdf1.21 MBAdobe PDFDownload
Title: Noninvasive myocardial endothelial intervention in the persistence of coronary stenosis: a concept of myocardial endothelial nitric oxide activator through heart failure research on clinical demand
Other Titles: Nitric oxide activators in failing heart
Authors: Yaoita, Hiroyuki
Watanabe, Kenichi
Ogawa, Kazuei
Maruyama, Yukio
Affiliation: 内科学第一講座
Source title: Fukushima Journal of Medical Science
Volume: 51
Issue: 2
Start page: 51
End page: 66
Issue Date: Dec-2005
Abstract: Protection of ischemic myocardium has been attempted by a variety of pharmaceutical and non-pharmaceutical methods. When the coronary intervention is not indicated by some reasons in patients with ischemic heart failure, medical treatments are expected to offer cardioprotection against the persistence of stenotic/occlusive lesions of the epicardial coronary artery. The pharmaceuticals such as the angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, beta blocker, Ca antagonist, ATP-sensitive K channel opener and statin, or non-pharmaceutical approaches such as physical exercise, cardiac resynchronization, ventricular assist devices, and preconditioning upon ischemic insults appear to improve myocardial endothelial nitric oxide (NO) synthase (eNOS) function. Such eNOS activation contributes to amelioration of the cardiac dysfunction and remodeling induced by myocardial ischemia. Therefore, based on clinical evidence and basic research on clinical demand, we postulate a concept of 'myocardial endothelial NO activator' from the standpoint of mechanistic insights beyond the class-effects of each pharmaceutical category and each non-pharmaceutical intervention. In addition to such continuous eNOS activation for treating chronic ischemic heart failure, rapid eNOS activation in the setting of acute ischemic events upon chronic myocardial ischemia by new strategies such as postconditioning seems to be also essential for developing further effective anti-heart-failure therapies.
Publisher: The Fukushima Society of Medical Science
Publisher (Alternative foam): 福島医学会
language: eng
URI: http://ir.fmu.ac.jp/dspace/handle/123456789/171
Full text URL: http://ir.fmu.ac.jp/dspace/bitstream/123456789/171/1/FksmJMedSci_51_p51.pdf
ISSN: 0016-2590
DOI: 10.5387/fms.51.51
PubMed ID: 16555626
Related Page: https://doi.org/10.5387/fms.51.51
Rights: © 2005 The Fukushima Society of Medical Science
Appears in Collections:Vol.51 (2005)

Files in This Item:

File Description SizeFormat
FksmJMedSci_51_p51.pdf1.21 MBAdobe PDFDownload

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.


DSpace Software Copyright © 2002-2007 MIT and Hewlett-Packard